{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T04:11:37Z","timestamp":1792987897292,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":2135,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1038\/ki.2009.466","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T08:36:49Z","timestamp":1260347809000},"page":"292-298","source":"Crossref","is-referenced-by-count":147,"title":["FGF23\u2013parathyroid interaction: implications in chronic kidney disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Hirotaka","family":"Komaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2009.466_bb0010","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.01520407","article-title":"Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism","volume":"2","author":"Felsenfeld","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.466_bb0015","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI112714","article-title":"Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat","volume":"78","author":"Silver","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.466_bb0020","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0021-9258(18)69191-4","article-title":"5\u2032-Flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3","volume":"263","author":"Okazaki","year":"1988","journal-title":"J Biol Chem"},{"issue":"Suppl 85","key":"10.1038\/ki.2009.466_bb0025","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1046\/j.1523-1755.63.s85.3.x","article-title":"Vitamin D receptor: mechanisms for vitamin D resistance in renal failure","volume":"63","author":"Dusso","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ki.2008.642","article-title":"Phosphate and the parathyroid","volume":"75","author":"Silver","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0035","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","volume":"118","author":"Quarles","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.466_bb0040","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2009.466_bb0045","doi-asserted-by":"crossref","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2009.466_bb0050","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben Dov","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.466_bb0055","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1677\/JOE-07-0267","article-title":"Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells","volume":"195","author":"Krajisnik","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1038\/ki.2009.466_bb0060","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2009.466_bb0065","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2009.466_bb0070","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.466_bb0075","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ki.2009.246","article-title":"A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease","volume":"76","author":"Isakova","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0080","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/81664","article-title":"Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23","volume":"26","author":"ADHR Consortium","year":"2000","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2009.466_bb0085","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.466_bb0090","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.466_bb0095","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.466_bb0100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.466_bb0105","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"10.1038\/ki.2009.466_bb0110","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2009.466_bb0115","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pag\u00e8s","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1038\/ki.2009.466_bb0120","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1210\/en.2005-0431","article-title":"Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed","volume":"146","author":"Larsson","year":"2005","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.466_bb0125","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","article-title":"Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo","volume":"143","author":"Shimada","year":"2002","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.466_bb0130","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by Klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1038\/ki.2009.466_bb0135","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1038\/ki.2009.466_bb0140","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2009.466_bb0145","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1359\/jbmr.080417","article-title":"Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23","volume":"23","author":"Yamazaki","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2009.466_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse Klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1038\/ki.2009.466_bb0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1096\/fj.08-114397","article-title":"In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB J"},{"key":"10.1038\/ki.2009.466_bb0160","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1096\/fj.08-123992","article-title":"Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model","volume":"23","author":"Nakatani","year":"2009","journal-title":"FASEB J"},{"key":"10.1038\/ki.2009.466_bb0165","doi-asserted-by":"crossref","first-page":"E79","DOI":"10.1152\/ajpendo.90539.2008","article-title":"Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype","volume":"296","author":"Bai","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2009.466_bb0170","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2007121301","article-title":"FGFR3 and FGFR4 do not mediate renal effects of FGF23","volume":"19","author":"Liu","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.466_bb0175","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2009.466_bb0180","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0185","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.466_bb0190","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentration of fibroblast growth factor 23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2009.466_bb0195","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.466_bb0200","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1681\/ASN.2008121258","article-title":"Indirect regulation of PTH by estrogens may require FGF23","volume":"20","author":"Carrillo-L\u00f3pez","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.466_bb0205","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1073\/pnas.0712361105","article-title":"A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism","volume":"105","author":"Brownstein","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2009.466_bb0210","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0215","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"10.1038\/ki.2009.466_bb0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ndt\/11.supp3.130","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"11","author":"Slatopolsky","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.466_bb0225","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0230","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.466_bb0235","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.466_bb0240","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ndt\/gfh827","article-title":"With or without the kidney: the role of FGF23 in CKD","volume":"20","author":"Fukagawa","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.466_bb0245","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1046\/j.1523-1755.2001.00755.x","article-title":"Post-transplant hypophosphatemia","volume":"59","author":"Levi","year":"2001","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0250","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/sj.ki.5001788","article-title":"Post-transplant hypophosphatemia: tertiary \u2018hyper-phosphatoninism\u2019?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0255","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1600-6143.2007.01753.x","article-title":"Tertiary \u2018hyperphosphatoninism\u2019 accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients","volume":"7","author":"Evenepoel","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1038\/ki.2009.466_bb0260","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.2215\/CJN.01310308","article-title":"Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation","volume":"3","author":"Evenepoel","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2009.466_bb0265","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1399-0012.2009.00995.x","article-title":"1,25-Dihydroxyvitamin D synthesis after renal transplantation: the role of fibroblast growth factor 23 and cyclosporine","volume":"23","author":"Sato","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1038\/ki.2009.466_bb0270","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1359\/jbmr.090509","article-title":"Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets\/osteomalacia","volume":"24","author":"Aono","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"Suppl 102","key":"10.1038\/ki.2009.466_bb0275","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1038\/sj.ki.5001594","article-title":"Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease","volume":"70","author":"Fukagawa","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<78::AID-SSU3>3.0.CO;2-Z","article-title":"pathophysiology, and indications for surgical treatment of renal hyperparathyroidism","volume":"13","author":"Tominaga","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1038\/ki.2009.466_bb0285","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2009.466_bb0290","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ki.1997.41","article-title":"Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism","volume":"51","author":"Gogusev","year":"1997","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2009.466_bb0295","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2009.466_bb0300","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2009.466_bb0305","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2009.466_bb0310","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1093\/ndt\/gfp323","article-title":"As nature did not predict dialysis\u2014what we can learn from FGF23 in end-stage renal disease?","volume":"24","author":"Ketteler","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2009.466_bb0315","article-title":"Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients","author":"Komaba","year":"2009","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815542555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815542555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T16:31:30Z","timestamp":1634315490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815542555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0085253815542555"],"URL":"https:\/\/doi.org\/10.1038\/ki.2009.466","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}